Design of Uracil-Modified DNA Nanotubes for Targeted Drug Release via DNA-Modifying Enzyme Reactions
- 22 July 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (30) , 34470-34479
Abstract
DNA nanostructure-based responsive drug delivery has become an increasingly potent method in cancer therapy. However, a variety of important cancer biomarkers have not been explored in searching of new and efficient targeted delivery systems. Uracil degradation glycosylase and human apurinic/apyrimidinic endonuclease are significantly more active in cancer cells. Here, we developed uracil-modified DNA nanotubes that can deliver drugs to tumor cells through an enzyme-induced disassembly process. Although the reaction of these enzymes on their natural DNA substrates has been established, their reactivity on self-assembled nanostructures of nucleic acids is not well understood. We leveraged molecular dynamic simulation based on coarse-grained model to forecast the enzyme reactivity on different DNA designs. The experimental data are highly consistent with the simulation results. It is the first example of molecule simulation being used to guide the design of enzyme-responsive DNA nano-delivery systems. Importantly, we found that the efficiency of drug release from the nanotubes can be regulated by tuning the positions of uracil modification. The DNA nanotubes equipped with cancer-specific aptamer AS1411 are used to deliver doxorubicin to tumor-bearing mice not only effectively inhibiting tumor growth but also protecting major organs from drug-caused damage. We believe that this work provides new knowledge on and insights into future design of enzyme-responsive DNA-based nanocarriers for drug delivery.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2019YFC1200500, 2019YFC1200502)
- Natural Science Foundation of Beijing Municipality (5212013)
- Capital Health Research and Development of Special Fund (021-1G-4302)
- Central University Basic Research Fund of China (XK-2020-08)
- National Natural Science Foundation of China (31971361)
This publication has 54 references indexed in Scilit:
- Direct Mechanical Measurements Reveal the Material Properties of Three-Dimensional DNA OrigamiNano Letters, 2011
- Self-Assembled Multivalent DNA Nanostructures for Noninvasive Intracellular Delivery of Immunostimulatory CpG OligonucleotidesACS Nano, 2011
- A primer to scaffolded DNA origamiNature Methods, 2011
- Structural, mechanical, and thermodynamic properties of a coarse-grained DNA modelThe Journal of Chemical Physics, 2011
- Human AP endonuclease 1 (APE1): From mechanistic insights to druggable target in cancerCancer Treatment Reviews, 2010
- Rapid prototyping of 3D DNA-origami shapes with caDNAnoNucleic Acids Research, 2009
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer CellsCancer Research, 2008
- Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cellsCell Research, 2008
- Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxideLife Sciences, 2005
- Design and Characterization of Programmable DNA NanotubesJournal of the American Chemical Society, 2004